Literature DB >> 12869110

Single hospital experience of TRALI.

Jonathan P Wallis1, Anatole Lubenko, Angus W Wells, Catherine E Chapman.   

Abstract

BACKGROUND: TRALI is a serious adverse effect of blood transfusion. There is evidence that the condition is underrecognized and underreported. STUDY DESIGN AND METHODS: This study was an observational study carried out in a single hospital.
RESULTS: Eleven cases of TRALI were recognized over 12 years. In 10 cases the implicated donor unit was FFP and in 1 case uncertain. All implicated donors were parous women. In 4 cases the presumed causative antibodies were to an HLA class II antigen only. Specific anti-neutrophil antibodies, possibly causative, were detected in 1 case only. Ten of the 11 cases required mechanical ventilatory support. Five persons died as a result of the TRALI. The observed incidence of TRALI caused by FFP is 1 in 7900 units transfused.
CONCLUSION: TRALI is the most common serious adverse effect of blood transfusion in our hospital. Antibodies to HLA class II antigens should be looked for routinely when investigating a possible case of TRALI.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869110     DOI: 10.1046/j.1537-2995.2003.00466.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  27 in total

1.  Transfusion-Related Acute Lung Injury: Incidence, Pathogenesis and the Role of Multicomponent Apheresis in Its Prevention.

Authors:  Mark A Popovsky
Journal:  Transfus Med Hemother       Date:  2008-03-10       Impact factor: 3.747

2.  A case of transfusion related acute lung injury in a thalassemic child.

Authors:  Anupama Agrawal; Deepak Kumar; Tarun Verma; Rakesh Gupta
Journal:  Med J Armed Forces India       Date:  2014-08-14

Review 3.  Protocols for massive blood transfusion: when and why, and potential complications.

Authors:  E Guerado; A Medina; M I Mata; J M Galvan; M L Bertrand
Journal:  Eur J Trauma Emerg Surg       Date:  2015-12-09       Impact factor: 3.693

Review 4.  [Fresh plasma and concentrates of clotting factors for therapy of perioperative coagulopathy: what is known?].

Authors:  B Heindl; M Spannagl
Journal:  Anaesthesist       Date:  2006-09       Impact factor: 1.041

5.  Long-term survival and quality of life after transfusion-associated pulmonary edema in critically ill medical patients.

Authors:  Guangxi Li; Marija Kojicic; Martin K Reriani; Evans R Fernández Pérez; Lokendra Thakur; Rahul Kashyap; Camille M Van Buskirk; Ognjen Gajic
Journal:  Chest       Date:  2009-10-16       Impact factor: 9.410

6.  Transfusion-Related Acute Lung Injury (TRALI): Report of 2 Cases and a Review of The Literature.

Authors:  Bobby D Nossaman
Journal:  Ochsner J       Date:  2008

Review 7.  Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill.

Authors:  Alexander B Benson; Marc Moss; Christopher C Silliman
Journal:  Br J Haematol       Date:  2009-08-05       Impact factor: 6.998

Review 8.  The role of neutrophils in the pathogenesis of transfusion-related acute lung injury.

Authors:  Yoke Lin Fung; Christopher C Silliman
Journal:  Transfus Med Rev       Date:  2009-10

Review 9.  Transfusion-related acute lung injury (TRALI): current concepts and misconceptions.

Authors:  Christopher C Silliman; Yoke Lin Fung; J Bradley Ball; Samina Y Khan
Journal:  Blood Rev       Date:  2009-08-20       Impact factor: 8.250

10.  Role of Riboflavin- and UV Light-Treated Plasma in Prevention of Transfusion-Related Acute Lung Injury.

Authors:  Teresa Jimenez-Marco; Daniel Ruiz-Alderton; Antonia M Bautista-Gili; Enrique Girona-Llobera
Journal:  Transfus Med Hemother       Date:  2014-05-12       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.